This topic contains a solution. Click here to go to the answer

Author Question: The patient in the emergency department experienced an acute myocardial infarction (MI) 8 hours ago. ... (Read 35 times)

CORALGRILL2014

  • Hero Member
  • *****
  • Posts: 525
The patient in the emergency department experienced an acute myocardial infarction (MI) 8 hours ago. The nurse is administering reteplase (Retavase) intravenously (IV). The patient asks the nurse what is being done. What is the best response by the nurse?
 
  1. This medicine is widening the arteries in your heart so they can get more oxygen.
  2. This medication is dissolving the clot that is causing your heart attack.
  3. This medicine is thinning your blood so more clots will not develop.
  4. No response is indicated; the patient is past the time frame where thrombolytic therapy is effective.

Question 2

The nurse has completed medication education with the patient who is receiving atenolol (Tenormin). The nurse determines that teaching is effective when the patient makes which statement?
 
  1. I must avoid grapefruit juice when I take this medicine.
  2. I must call my doctor if I want to stop this medicine.
  3. I must check my pulse before taking the medicine, and call the doctor if it is less than 50.
  4. I must take this medicine with food so it will be properly absorbed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xMRAZ

  • Sr. Member
  • ****
  • Posts: 363
Answer to Question 1

Correct Answer: 2
Rationale: When treating myocardial infarction (MI), thrombolytic therapy is administered to dissolve clots obstructing the coronary arteries, thus restoring circulation to the myocardium. Thrombolytics dissolve clots in coronary arteries; they are not vasodilators. Thrombolytics are most effective when administered from 20 minutes to 12 hours after the onset of myocardial infarction (MI) symptoms; this patient is within the time frame. Thrombolytics dissolve clots in coronary arteries, they are not anticoagulants.

Answer to Question 2

Correct Answer: 2
Rationale: When beta blockers are abruptly discontinued, adrenergic receptors are stimulated causing excitation. This could result in tachycardia or myocardial infarction (MI). Atenolol (Tenormin) may be taken with or without food. Atenolol (Tenormin) is not metabolized through the CYP 450 chromosome system, so grapefruit juice is not contraindicated. Patients should check their pulse prior to taking atenolol (Tenormin), but they should call the physician if the pulse is less than 60, not 50.




CORALGRILL2014

  • Member
  • Posts: 525
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Gracias!

 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Although the Roman numeral for the number 4 has always been taught to have been "IV," according to historians, the ancient Romans probably used "IIII" most of the time. This is partially backed up by the fact that early grandfather clocks displayed IIII for the number 4 instead of IV. Early clockmakers apparently thought that the IIII balanced out the VIII (used for the number 8) on the clock face and that it just looked better.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library